Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ablynx
Ablynx
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Fierce Biotech
Thu, 04/27/23 - 11:40 am
Sanofi
M&A
earnings
Ablynx
Principia Biopharma
Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug
Endpoints
Tue, 09/4/18 - 05:01 pm
Ablynx
Sanofi
Europe
caplacizumab
M&A
aTTP
Sanofi CEO: $16 Billion Deal Binge Does Not Represent A Change In Strategy
Forbes
Mon, 01/29/18 - 03:26 pm
Sanofi
Pharma CEOs
Olivier Brandicourt
M&A
Ablynx
Bioverativ
Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom
Yahoo/Reuters
Mon, 01/29/18 - 10:33 am
Sanofi
Novo Nordisk
M&A
biotech
Ablynx
Novo Nordisk puts $3B on the table for Ablynx
Biopharma Dive
Mon, 01/8/18 - 11:48 am
Novo Nordisk
Ablynx
M&A
Sanofi offers Ablynx billions of biobucks for nanobody partnership
Fierce Biotech
Thu, 07/20/17 - 11:26 am
Sanofi
Ablynx
nanobodies
R&D
Ablynx files rare blood disorder drug, raising prospect of first commercial product next year
Fierce Biotech
Tue, 02/7/17 - 10:32 am
Ablynx
caplacizumab
Europe
aTTP
No surprise: AbbVie turns cold shoulder to a messy rheumatoid arthritis partnership with Ablynx
Endpoints
Thu, 10/20/16 - 09:34 am
AbbVie
rheumatoid arthritis
Ablynx
vobarilizumab
Why AbbVie Won't Pull A Galapagos On Ablynx
Seeking Alpha
Tue, 08/30/16 - 09:47 am
AbbVie
Galapagos
Ablynx
vobarilizumab
Will AbbVie bite? Decision time after Ablynx’s rheumatoid arthritis drug fails a key study
Endpoints
Tue, 08/9/16 - 10:46 pm
Ablynx
AbbVie
rheumatoid arthritis
vobarilizumab
Ablynx burns more cash in first half of 2015
Yahoo/Reuters
Thu, 08/27/15 - 09:50 am
Ablynx
Genzyme, Ablynx form multiple sclerosis pact
Pharma Times
Mon, 05/18/15 - 11:29 am
Genzyme
Ablynx
MS
multiple sclerosis
R&D
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
Ablynx agrees Merck cancer deal worth up to 1.7 billion euros
Yahoo/Reuters
Mon, 02/3/14 - 08:50 am
Ablynx
Merck
immunotherapy
China Biotech In Review: WuXi Laboratory The Only CLIA-Certified Clinical Lab In China
Seeking Alpha
Sun, 10/20/13 - 02:47 pm
China
Eddingpharm
Ablynx
Dance Biopharm
Miraculins
Cachet Pharma
CardioKinetix
WuXi PharmaTech
How AbbVie Plans to Survive After Humira
Motley Fool
Fri, 09/27/13 - 08:20 am
AbbVie
Humira
Ablynx
ALX-0061
Ablynx Rises on Drug Licensing Deal With AbbVie
Bloomberg
Mon, 09/23/13 - 09:17 am
Ablynx
AbbVie
ALX-0061
rheumatoid arthritis
Analysis: Maturing Belgian biotechs outshine European peers
Reuters
Thu, 10/4/12 - 10:48 am
Belgium
ThromboGenics
Ablynx
Ablynx enters alliance with Merck worth up to 448 million euros
Reuters
Tue, 10/2/12 - 09:54 am
Ablynx
Merck
Ablynx trial data sweetens partnering prospects
Reuters
Mon, 07/2/12 - 01:17 pm
Ablynx
ATN-103
rheumatoid arthritis